Paper23907171
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.
Mali P and 7 others. Nat Biotechnol, 2013. Cited by 1,364 papers, by iCite.
Cite this record
ConductScience Library. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Papers, record 23907171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23907171
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Associated Proteins | Major topic |
| Deoxyribonuclease I | Major topic |
| Genetic Engineering | Major topic |
| Trans-Activators | Major topic |
| Base Sequence | |
| HEK293 Cells | |
| Humans | |
| Models, Genetic | |
| Molecular Sequence Data | |
| RNA, Small Untranslated |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P50 HG005550 | NHGRI NIH HHS | United States | P50HG005550 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 24022156 | Staying on target with CRISPR-Cas. | https://conductscience.org/library/papers/24022156 |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19933107 | Breaking the code of DNA binding specificity of TAL-type III effectors. | Science | 2009 | https://conductscience.org/library/papers/19933107 | PubMed |
| 2 | 23360964 | Efficient genome editing in zebrafish using a CRISPR-Cas system. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360964 | PubMed |
| 3 | 23396285 | Robust, synergistic regulation of human gene expression using TALE activators. | Nat Methods | 2013 | https://conductscience.org/library/papers/23396285 | PubMed |
| 4 | 22949671 | Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22949671 | PubMed |
| 5 | 23377379 | Synergistic and tunable human gene activation by combinations of synthetic transcription factors. | Nat Methods | 2013 | https://conductscience.org/library/papers/23377379 | PubMed |
| 6 | 19933106 | A simple cipher governs DNA recognition by TAL effectors. | Science | 2009 | https://conductscience.org/library/papers/19933106 | PubMed |
| 7 | 21248753 | Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/21248753 | PubMed |
| 8 | 22371081 | Massively parallel functional dissection of mammalian enhancers in vivo. | Nat Biotechnol | 2012 | https://conductscience.org/library/papers/22371081 | PubMed |
| 9 | 21813460 | The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21813460 | PubMed |
| 10 | 22781676 | TAL effector RVD specificities and efficiencies. | Nat Biotechnol | 2012 | https://conductscience.org/library/papers/22781676 | PubMed |
| 11 | 23287718 | Multiplex genome engineering using CRISPR/Cas systems. | Science | 2013 | https://conductscience.org/library/papers/23287718 | PubMed |
| 12 | 23386978 | RNA-programmed genome editing in human cells. | Elife | 2013 | https://conductscience.org/library/papers/23386978 | PubMed |
| 13 | 21822273 | Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. | Nat Methods | 2011 | https://conductscience.org/library/papers/21822273 | PubMed |
| 14 | 16082368 | Gene targeting using zinc finger nucleases. | Nat Biotechnol | 2005 | https://conductscience.org/library/papers/16082368 | PubMed |
| 15 | 21910633 | Double-strand break end resection and repair pathway choice. | Annu Rev Genet | 2011 | https://conductscience.org/library/papers/21910633 | PubMed |
| 16 | 23360965 | RNA-guided editing of bacterial genomes using CRISPR-Cas systems. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360965 | PubMed |
| 17 | 12546792 | Single mRNA molecules demonstrate probabilistic movement in living mammalian cells. | Curr Biol | 2003 | https://conductscience.org/library/papers/12546792 | PubMed |
| 18 | 22484455 | FLASH assembly of TALENs for high-throughput genome editing. | Nat Biotechnol | 2012 | https://conductscience.org/library/papers/22484455 | PubMed |
| 19 | 22222791 | A transcription activator-like effector toolbox for genome engineering. | Nat Protoc | 2012 | https://conductscience.org/library/papers/22222791 | PubMed |
| 20 | 23408851 | Quantitative analysis of TALE-DNA interactions suggests polarity effects. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23408851 | PubMed |
Cited by996
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,364 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42861852 | Genome-wide mapping of Cas9-induced sister chromatid exchange across single and over 200 genomic sites in human cells. | Elife | 2026 | https://conductscience.org/library/papers/42861852 | PubMed |
| 42765712 | Targeted, genome-scale overexpression in Proteobacteria. | mBio | 2026 | https://conductscience.org/library/papers/42765712 | PubMed |
| 42758820 | A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo. | Sci Adv | 2026 | https://conductscience.org/library/papers/42758820 | PubMed |
| 42510658 | Histone H3 Acetylation at Sox1ot Promoter by Targeted Epigenome Editing Augments Proliferation of Intermediate Progenitors in Developing Cortex. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42510658 | PubMed |
| 42282825 | Combinatorial and Inducible CRISPRa/i Enables Canalized hiPSC Forward Programming and Iterative Refinement via Single-Cell Genomics. | bioRxiv | 2026 | https://conductscience.org/library/papers/42282825 | PubMed |
| 41937789 | Research progress and applications of gene activation editing technology in crops. | Front Plant Sci | 2026 | https://conductscience.org/library/papers/41937789 | PubMed |
| 41762821 | Advances in multiplex precision genome editing in eukaryotic and prokaryotic systems. | Curr Opin Biotechnol | 2026 | https://conductscience.org/library/papers/41762821 | PubMed |
| 41736562 | A robust cis-regulatory network ensures Otx2 expression during retinal development. | Development | 2026 | https://conductscience.org/library/papers/41736562 | PubMed |
| 41640466 | Engineering delivery platforms for CRISPR-Cas and their applications in healthcare, agriculture and beyond. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/41640466 | PubMed |
| 41613450 | Gene circuit-based sensors. | Fundam Res | 2025 | https://conductscience.org/library/papers/41613450 | PubMed |
| 41603736 | Conformational dynamics of CRISPR-Cas type I-F-HNH inform nickase engineering in a cascade scaffold. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/41603736 | PubMed |
| 41536997 | Recruitment of transcriptional effectors by Cas9 creates cis-regulatory elements and demonstrates distance-dependent transcriptional regulation. | iScience | 2026 | https://conductscience.org/library/papers/41536997 | PubMed |
| 41479407 | Engineered AcrIIA5 for optogenetic control of CRISPR-Cas9-based genome editing. | mLife | 2025 | https://conductscience.org/library/papers/41479407 | PubMed |
| 41322270 | Development of cell labeling and gene editing tools in urochordate Ciona. | Mar Life Sci Technol | 2025 | https://conductscience.org/library/papers/41322270 | PubMed |
| 41266370 | Combinatorial protein engineering identifies potent CRISPR activators with reduced toxicity. | Nat Commun | 2025 | https://conductscience.org/library/papers/41266370 | PubMed |
| 41249116 | Family with sequence similarity 114 member A1 orchestrates immune evasion in triple-negative breast cancer. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41249116 | PubMed |
| 41240134 | CRISPR-Cas9 in leukemia immunotherapy: precision engineering of CAR-T cells and tumor-microenvironment modulation. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41240134 | PubMed |
| 41223195 | Improved CRISPR/Cas9 off-target prediction with DNABERT and epigenetic features. | PLoS One | 2025 | https://conductscience.org/library/papers/41223195 | PubMed |
| 41190236 | Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing. | Mol Ther Oncol | 2025 | https://conductscience.org/library/papers/41190236 | PubMed |
| 41171314 | CRISPR-based gene therapy for huntington's disease: current advances and future prospects. | Neurogenetics | 2025 | https://conductscience.org/library/papers/41171314 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23907171
GET https://conductscience.org/api/papers/v1/23907171/references?page=2